News
-
Actualités
Gene-editing Therapy CTX-001 Granted Priority Medicines Designation for Severe SCD in EU
CTX001, an investigational gene-editing cell therapy, has been granted priority medicines (PRIME) designation by the European Medicines Agency (EMA) for the treatment of severe sickle…
Lire la suite » -
Actualités
Iranian Blood Transfusion Organization Newsletter
The Iranian Blood Transfusion Organization (IBTO) and its most recent activities are featured on TIF’S website.
Lire la suite » -
Actualités
COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine
As large parts of the world prepare for a second wave of coronavirus cases governments have pinned their hopes on…
Lire la suite » -
Actualités
eThalED Webinar Series: Heart Disease in Thalassaemia
Last -but not least- in our eThalED Webinar Series for Medical Specialists comes ‘Heart Disease in Thalassaemia’, one the major…
Lire la suite » -
Actualités
TIF’s Latest Newsletter Issue Is Out!
Our August 2020 newsletter has just been published! Read about our latest updates, including country activities, international projects, educational updates…
Lire la suite » -
Actualités
Revisiting The Use and Management of Blood in Europe in Times of Crisis and Beyond
About 25 million blood transfusions are administered to patients every year throughout the European Union. What may come to mind…
Lire la suite » -
Actualités
AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt
AstraZeneca Plc and the University of Oxford have resumed the British clinical trials of its Covid-19 vaccine, after the initial…
Lire la suite » -
Actualités
The »International Blood Diseases Symposium » Is Just Around The Corner
The Turkish Federation of Blood Diseases, Kan Hastalıkları Federasyonu is joining forces with TIF for the organisation of the »International…
Lire la suite » -
Actualités
Coming Up: A TIF Live Webinar on »Heart Disease in Thalassaemia »
Tune in with TIF on Tuesday, 15 September 2020, 15:00 EEST, for one of the last webinars from the TIF…
Lire la suite »